Giuseppe Rossi

4PUBLICATIONS
52CO-AUTHORS
NanomedicineAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Feb 27, 2026
Autologous Stem Cell Transplantation in HIV-Positive and HIV-Negative Patients with Lymphoma: A Propensity Score-Matched Comparative Analysis.

Alessandro Re, Margherita Oberti, Armando Stabile

|Mar 08, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study.

Alessandra Tucci, Alessandro Re, Chiara Pagani

|Jan 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda.

Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi

Pageof 1

Frequent Collaborators

2 joint publications

Erika Borlenghi

2 joint publications

Mauro Turrini

2 joint publications

Marco Frigeni

2 joint publications

Chiara Cattaneo